SCHEMBL22491645

SCHEMBL22491645

COC(=O)C(C)(C)c1nc(N)sc1OC

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.40
HPGD P15428 2/20 0.40
KDM4E B2RXH2 4/20 0.35
PKM P14618 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
HTT P42858 1/20 0.32
TP53 P04637 1/20 0.31
RAB9A P51151 1/20 0.31
POLB P06746 1/20 0.31
LMNA P02545 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP1A2 P05177 1/20 0.30
GFER P55789 1/20 0.30
MAPT P10636 1/20 0.30
RCE1 Q9Y256 1/20 0.30
PLCG1 P19174 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21044504 0.82 ALDH1A1 (0.44) ALDH1A1HPGDKDM4EPKMSMN1; SMN2
SCHEMBL22491637 0.81 ALDH1A1 (0.40) ALDH1A1HPGDKDM4EPKMSMN1; SMN2
SCHEMBL22869144 0.70 CTPS1 (0.37)
SCHEMBL23412984 0.69 KDM4E (0.55) ALDH1A1HPGDKDM4EPKMSMN1; SMN2
SCHEMBL21044247 0.66 TSHR (0.48) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL2325073 0.65 ALDH1A1 (0.54) ALDH1A1HPGDKDM4ESMN1; SMN2HSD17B10
SCHEMBL16636990 0.64 ALDH1A1 (0.42) ALDH1A1HPGDKDM4EPKMSMN1; SMN2
SCHEMBL1417177 0.63 ALDH1A1 (0.39) ALDH1A1HPGDKDM4EPKMSMN1; SMN2
SCHEMBL2173488 0.63
SCHEMBL13568254 0.63 CYP3A4 (0.36) KDM4EPKMHSD17B10HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3717459-B1 COMPOUNDS STEP PHARMA S A S (FR) 2026-01-21 EP disclosed
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2025-12-23 US disclosed
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2024-01-11 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 STEP PHARMA S.A.S. (FR) 2023-05-23 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
US-20210002269-A1 COMPOUNDS STEP PHARMA S.A.S. (FR) 2021-01-07 US disclosed
EP-3717459-A1 COMPOUNDS Step Pharma S.A.S. (FR) 2020-10-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12503466-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885HPGD 2098/4885KDM4E 4120/4885
US-11655246-B2 Aminothiazole compounds as inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885HPGD 2098/4885KDM4E 4120/4885
US-20210002269-A1 COMPOUNDS UGT1A1, CYP1A1, CYP19A1 ALDH1A1 181/4885HPGD 951/4885KDM4E 4411/4885
US-20240010645-A1 Aminothiazole Compounds as Inhibitors of CTPS1 CTPS1, CTPS2, TBXAS1 ALDH1A1 3425/4885HPGD 2098/4885KDM4E 4120/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.